<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Sharp Corporation — News on 6ix</title>
<link>https://6ix.com/company/sharp-corporation</link>
<description>Latest news and press releases for Sharp Corporation on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 13:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/sharp-corporation" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d62f0fbeedb30cb6fc8c4b.webp</url>
<title>Sharp Corporation</title>
<link>https://6ix.com/company/sharp-corporation</link>
</image>
<item>
<title>Sharp and Taktiful Announce Strategic Alliance To Simplify Embellished Production Print</title>
<link>https://6ix.com/company/sharp-corporation/news/sharp-and-taktiful-announce-strategic-alliance-to-simplify-embellished-production-print</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/sharp-and-taktiful-announce-strategic-alliance-to-simplify-embellished-production-print</guid>
<pubDate>Tue, 21 Apr 2026 13:00:00 GMT</pubDate>
<description>Sharp Imaging and Information Company of America (SIICA), a division of Sharp Electronics Corporation, today announced that Taktiful Software Solutions has joined the Sharp Partner Program. The Taktiful Reaktor platform will be a key resource in delivering advanced digital embellishment solutions that will complement the Sharp BP-1200S Production Print Platform.</description>
</item>
<item>
<title>Sharp Therapeutics Corp. Announces Fourth Quarter 2025 Results, Closing of Convertible Note Offering and Adoption of Semi-Annual Reporting</title>
<link>https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-corp-announces-fourth-quarter-2025-results-closing-of-convertible-note-offering-and-adoption-of-semi-annual-reporting-1</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-corp-announces-fourth-quarter-2025-results-closing-of-convertible-note-offering-and-adoption-of-semi-annual-reporting-1</guid>
<pubDate>Fri, 17 Apr 2026 22:13:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 17, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") announces the release of its annual audited consolidated financial statements for the year ended December 31, 2025, and related management discussion and analysis ("MD&A") and annual information form. All dollar figures are in United States dollars, unless otherwise stated. Scott Sneddon, Sharp's Chief Executive Officer, stated: "Our..</description>
</item>
<item>
<title>Sharp Therapeutics Updates on '901 for Gaucher and GBA1 Parkinson's and Platform Programs</title>
<link>https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-updates-on-901-for-gaucher-and-gba1-parkinsons-and-platform-programs-1</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-updates-on-901-for-gaucher-and-gba1-parkinsons-and-platform-programs-1</guid>
<pubDate>Fri, 10 Apr 2026 21:05:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") announces that following longer-term non-GLP testing the company has decided to advance an alternative compound for its Gaucher and GBA1 Parkinson's programs. The company continues to advance all platform programs including programs for genetic and sporadic forms of neurodegeneration (Progranulin modulators), and a rare...</description>
</item>
<item>
<title>Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering</title>
<link>https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-announces-closing-of-fourth-tranche-of-unsecured-convertible-note-offering-1</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-announces-closing-of-fourth-tranche-of-unsecured-convertible-note-offering-1</guid>
<pubDate>Fri, 10 Apr 2026 21:00:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has closed the fourth tranche (the "Fourth Tranche") of its previously announced non-brokered private placement for unsecured convertible notes of the Company (collectively, the "Notes"), in the principal amount of US$1,000 per Note (the "Note Offering"). Pursuant to completing the Fourth Tranche, the...</description>
</item>
<item>
<title>Sharp Therapeutics Announces Closing of Third Tranche of Unsecured Convertible Note Offering</title>
<link>https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-announces-closing-of-third-tranche-of-unsecured-convertible-note-offering-1</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-announces-closing-of-third-tranche-of-unsecured-convertible-note-offering-1</guid>
<pubDate>Thu, 02 Apr 2026 21:43:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 2, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has closed the third tranche (the "Third Tranche") of its previously announced non-brokered private placement for unsecured convertible notes of the Company (collectively, the "Notes"), in the principal amount of US$1,000 per Note (the "Note Offering"). Pursuant to completing the Third Tranche, the Company</description>
</item>
<item>
<title>Access Advance Welcomes New VDP Pool Licensors and Releases Independent Economic Analysis Confirming FRAND Compliance</title>
<link>https://6ix.com/company/sharp-corporation/news/access-advance-welcomes-new-vdp-pool-licensors-and-releases-independent-economic-analysis-confirming-frand-compliance</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/access-advance-welcomes-new-vdp-pool-licensors-and-releases-independent-economic-analysis-confirming-frand-compliance</guid>
<pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
<description>BOSTON, March 24, 2026--Access Advance announces that Sharp Corporation, CB Cline, SK Planet, and Telechips, Inc have joined their Video Distribution Patent Pool (VDP Pool).</description>
</item>
<item>
<title>Sharp Therapeutics Announces Closing of Second Tranche of Unsecured Convertible Note Offering</title>
<link>https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-announces-closing-of-second-tranche-of-unsecured-convertible-note-offering-1</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-announces-closing-of-second-tranche-of-unsecured-convertible-note-offering-1</guid>
<pubDate>Fri, 13 Mar 2026 21:05:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - March 13, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its previously announced non-brokered private placement for unsecured convertible notes of the Company (collectively, the "Notes"), in the principal amount of US$1,000 per Note (the "Note Offering"). Pursuant to completing the Second Tranche, the...</description>
</item>
<item>
<title>Dynabook Canada Expands Nationwide Distribution Through TD SYNNEX</title>
<link>https://6ix.com/company/sharp-corporation/news/dynabook-canada-expands-nationwide-distribution-through-td-synnex</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/dynabook-canada-expands-nationwide-distribution-through-td-synnex</guid>
<pubDate>Tue, 03 Mar 2026 13:00:00 GMT</pubDate>
<description>Dynabook Laptops Now Available Through TD SYNNEX Canada Dynabook’s new agreement with TD SYNNEX Canada boosts product availability and streamlines procurement, enabling faster deployment of secure, durable business laptops nationwide. MISSISSAUGA, Ontario, March 03, 2026 (GLOBE NEWSWIRE) -- Dynabook Canada Inc. has signed a nationwide distribution agreement with TD SYNNEX, expanding access to its business-class laptop portfolio across Canada. The partnership improves product availability for res</description>
</item>
<item>
<title>Qualcomm and Other Industry Leaders Commit to 6G Trajectory Towards Commercialization Starting from 2029 Onwards</title>
<link>https://6ix.com/company/sharp-corporation/news/qualcomm-and-other-industry-leaders-commit-to-6g-trajectory-towards-commercialization-starting-from-2029-onwards-7</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/qualcomm-and-other-industry-leaders-commit-to-6g-trajectory-towards-commercialization-starting-from-2029-onwards-7</guid>
<pubDate>Mon, 02 Mar 2026 07:22:00 GMT</pubDate>
<description>BARCELONA, Spain, March 02, 2026--Qualcomm Technologies, Inc. (NASDAQ: QCOM) today announced a new strategic coalition with leading industry partners to accelerate the development and global deployment of 6G. Revealed at MWC Barcelona 2026, the collaboration establishes a clear, milestone-driven roadmap focused on delivering 6G commercial systems starting from 2029 onwards.</description>
</item>
<item>
<title>Sharp Therapeutics Announces Closing of First Tranche of Unsecured Convertible Note Offering</title>
<link>https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-announces-closing-of-first-tranche-of-unsecured-convertible-note-offering-1</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-announces-closing-of-first-tranche-of-unsecured-convertible-note-offering-1</guid>
<pubDate>Fri, 27 Feb 2026 22:21:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - February 27, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement for unsecured convertible notes of the Company (collectively, the "Notes"), in the principal amount of US$1,000 per Note (the "Note Offering"). Pursuant to completing the First Tranche, the...</description>
</item>
<item>
<title>D-Wave Reports Fourth Quarter and Year-End 2025 Results</title>
<link>https://6ix.com/company/sharp-corporation/news/d-wave-reports-fourth-quarter-and-year-end-2025-results-3</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/d-wave-reports-fourth-quarter-and-year-end-2025-results-3</guid>
<pubDate>Thu, 26 Feb 2026 12:00:00 GMT</pubDate>
<description>PALO ALTO, Calif., February 26, 2026--D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software, and services, today announced financial results for its fiscal fourth quarter and year ended December 31, 2025.</description>
</item>
<item>
<title>Atmus Filtration Technologies Appoints Heath Sharp to Its Board of Directors</title>
<link>https://6ix.com/company/sharp-corporation/news/atmus-filtration-technologies-appoints-heath-sharp-to-its-board-of-directors-1</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/atmus-filtration-technologies-appoints-heath-sharp-to-its-board-of-directors-1</guid>
<pubDate>Fri, 06 Feb 2026 11:43:00 GMT</pubDate>
<description>NASHVILLE, Tenn., February 06, 2026--Atmus Filtration Technologies Inc. (Atmus; NYSE: ATMU), a global leader in the filtration industry, today announced the appointment of Heath Sharp to its Board of Directors.</description>
</item>
<item>
<title>Sharp Honored as a Top Electronics Organization on 2026 Fortune World's Most Admired Companies List</title>
<link>https://6ix.com/company/sharp-corporation/news/sharp-honored-as-a-top-electronics-organization-on-2026-fortune-worlds-most-admired-companies-list-1</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/sharp-honored-as-a-top-electronics-organization-on-2026-fortune-worlds-most-admired-companies-list-1</guid>
<pubDate>Thu, 05 Feb 2026 14:00:00 GMT</pubDate>
<description>Sharp Electronics Corporation (SEC) is proud to announce that Sharp has been named to the Fortune World's Most Admired Companies list, marking the company's 5th year on the annual ranking. Sharp ranked #9 in the Electronics industry, underscoring the company's respected position in the market and positioning it among the world's leading global technology firms.</description>
</item>
<item>
<title>Sharp Therapeutics Announces Private Placement of up to US$3.0 Million in Unsecured Convertible Notes</title>
<link>https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-announces-private-placement-of-up-to-usdollar30-million-in-unsecured-convertible-notes</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-announces-private-placement-of-up-to-usdollar30-million-in-unsecured-convertible-notes</guid>
<pubDate>Mon, 02 Feb 2026 17:10:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - February 2, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce the terms of a proposed non-brokered private placement for an aggregate principal amount of up to US$3.0 million of unsecured convertible notes of the Company (collectively, the "Notes"), in the principal amount of US$1,000 per Note (the "Note Offering"). The Company anticipates that the initial closing of the.</description>
</item>
<item>
<title>Sharp Announces High-Performance SDM Computing with BrightSign® Built-In</title>
<link>https://6ix.com/company/sharp-corporation/news/sharp-announces-high-performance-sdm-computing-with-brightsignr-built-in</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/sharp-announces-high-performance-sdm-computing-with-brightsignr-built-in</guid>
<pubDate>Thu, 29 Jan 2026 16:00:00 GMT</pubDate>
<description>In a joint effort to drive innovation in digital signage solutions, Sharp Imaging and Information Company of America (SIICA) and Sharp Display Solutions Europe, the audio-visual technology business divisions of Sharp Electronics Corporation (SEC) and Sharp Europe, are introducing the upcoming Sharp SDM Player with BrightSign Built-In System-on-a-Chip (SoC) solution. Sharp's world-class professional Large Format Displays (LFD) are paired with BrightSign Built-In, the industry's leading SoC soluti</description>
</item>
<item>
<title>Sharp Therapeutics Appoints Co-Founder Of National Gaucher Foundation And Clinical Researcher Robin Ely, M.D., To Advisory Board</title>
<link>https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-appoints-co-founder-of-national-gaucher-foundation-and-clinical-researcher-robin-ely-md-to-advisory-board-1</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-appoints-co-founder-of-national-gaucher-foundation-and-clinical-researcher-robin-ely-md-to-advisory-board-1</guid>
<pubDate>Tue, 27 Jan 2026 12:00:00 GMT</pubDate>
<description>PITTSBURGH and TORONTO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Sharp Therapeutics Corp. ("Sharp" or the "Company") (TSX-V: SHRX) (OTCQB: SHRXF), a biotechnology company developing small-molecule therapeutics for genetic diseases, announced today the appointment of Robin Ely, M.D., the Clinical Director and co-founder of the National Gaucher Foundation (NGF), to its Advisory Board. Dr. Ely co-founded NGF in 1984 after her son was diagnosed with Gaucher disease. Dr. Ely played a pivotal role in facilit</description>
</item>
<item>
<title>Sharp Promotes Matt Petry to Senior Vice President, Sharp Business Systems</title>
<link>https://6ix.com/company/sharp-corporation/news/sharp-promotes-matt-petry-to-senior-vice-president-sharp-business-systems</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/sharp-promotes-matt-petry-to-senior-vice-president-sharp-business-systems</guid>
<pubDate>Thu, 08 Jan 2026 15:00:00 GMT</pubDate>
<description>Sharp Imaging and Information Company of America (SIICA), a division of Sharp Electronics Corporation (SEC), announced that Matt Petry has been appointed to Senior Vice President of Sharp Business Systems (SBS), SIICA's direct sales and service operations. Matt reports directly to SIICA President and CEO Mike Marusic and is responsible for all aspects of the direct sales business for SIICA. Matt steps into the position as Joe O'Malley retires after a noteworthy career at Sharp and other office t</description>
</item>
<item>
<title>Sharp Therapeutics Provides Update on Non-Brokered Private Placement and Grant of Options</title>
<link>https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-provides-update-on-non-brokered-private-placement-and-grant-of-options-1</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-provides-update-on-non-brokered-private-placement-and-grant-of-options-1</guid>
<pubDate>Fri, 19 Dec 2025 22:05:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - December 19, 2025) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company"), is pleased to announce that the non-brokered private placement to raise gross proceeds of not less than US$10,000,000 (the "Offering") previously announced on October 14, 2025 has been updated. The placement will consist of common shares in the capital of the Company priced at not less than US$2.50 per share. The Company expects...</description>
</item>
<item>
<title>Sharp Therapeutics Corp. Reports Third Quarter 2025 Results and Development Update</title>
<link>https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-corp-reports-third-quarter-2025-results-and-development-update-1</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/sharp-therapeutics-corp-reports-third-quarter-2025-results-and-development-update-1</guid>
<pubDate>Wed, 26 Nov 2025 12:35:00 GMT</pubDate>
<description>Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - November 26, 2025) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company"), announces the release of its condensed interim consolidated financial statements for the three and nine months ended September 30, 2025, and related management discussion and analysis. All dollar figures are in United States dollars, unless otherwise stated.Scott Sneddon, Sharp's Chief Executive Officer, stated: "Our Q3 financial..</description>
</item>
<item>
<title>Access Advance Announces Major Growth in Its HEVC and VVC Patent Pools</title>
<link>https://6ix.com/company/sharp-corporation/news/access-advance-announces-major-growth-in-its-hevc-and-vvc-patent-pools-1</link>
<guid isPermaLink="true">https://6ix.com/company/sharp-corporation/news/access-advance-announces-major-growth-in-its-hevc-and-vvc-patent-pools-1</guid>
<pubDate>Mon, 24 Nov 2025 15:10:00 GMT</pubDate>
<description>BOSTON, November 24, 2025--Access Advance LLC today announced significant expansions of both its HEVC Advance and VVC Advance Patent Pools during the second and third quarters of 2025, underscoring continued industry confidence in the company's balanced and transparent approach to video codec licensing. This growth follows the successful January 2025 launch of Access Advance's Video Distribution Patent ("VDP") Pool, demonstrating the company's expanding role in comprehensive video codec patent l</description>
</item>
</channel>
</rss>